Natera (NTRA) Q3 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 11/13/24
Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal CancerBusiness Wire • 11/12/24
All You Need to Know About Natera (NTRA) Rating Upgrade to Strong BuyZacks Investment Research • 10/23/24
Court Orders Permanent Injunction Against NeoGenomics' Accused RaDaR Assay, as Case Enters New PhaseBusiness Wire • 09/23/24
Natera Announces Three New Signatera Publications; Includes Groundbreaking Overall Survival Data Published in Nature Medicine and also Released at ESMOBusiness Wire • 09/16/24
First of its Kind Colorectal Cancer Data from Prospective GALAXY Study Released at ESMO; Demonstrates Signatera's Ability to Predict Overall SurvivalBusiness Wire • 09/14/24
Natera to Present New Signatera™ Colorectal Cancer Data at ESMO Showing 10X Advantage in Overall SurvivalBusiness Wire • 09/09/24
Natera to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceBusiness Wire • 08/28/24
Newell Brands' Sharpie and Paper Mate Pledge $1 Million to Boys & Girls Clubs of America to Inspire Creativity and Empower Youth NationwideBusiness Wire • 08/06/24
Enclara Pharmacia Announces Real-Time, Two-Way Medication Integration With MatrixCare's Electronic Health Record PlatformBusiness Wire • 08/06/24
New MultiCenter Prospective Study Demonstrates Signatera's Clinical Utility in Merkel Cell CarcinomaBusiness Wire • 07/26/24